BioSpace News Archive

The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases.

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of PEDMARK™ for the prevention of platinum-induced ototoxicity in pediatric patients, reported its financial results for the second quarter ended June 30, 2021 and provided a business update.

Kurin Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that July revenues represent their highest monthly total in their history.

Cullinan Oncology, Inc., an oncology company seeking to drive shareholder returns by focusing on the patient, announced its financial results for the second quarter ended June 30, 2021 and reported on recent business highlights.

Merck announced that the U.S. Food and Drug Administration has accepted and granted priority review for a new supplemental Biologics License Application for KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment of patients with renal cell carcinoma at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced that Dr Megan Baldwin, the Company’s Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Ophthalmology Virtual Conference being held August 17, 2021.

Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, announced financial results for the second quarter ended June 30, 2021, and highlighted recent corporate accomplishments.

Vecna Technologies, a leading provider of healthcare information technologies focused on patient intake, clinical surveillance and telepresence robotics, announced today the launch of the Vecna HealthPass Mobile App at the HIMSS Global Health Conference and Exhibition August 9-13, 2021 in Las Vegas, Nevada.

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the upcoming 2021 Society of Neuro-Oncology (SNO) Conference on Brain Metastases, to be held in a virtual format from August 19 to 20, 2021.

Infusion Associates (IA), a leading provider of medically prescribed outpatient infusion therapy, has begun recruiting patients across Michigan for an international COVID-19 study sponsored by the National Institute of Allergy and Infectious Diseases.